Physician

Alexis Renae Ogdie, MD

According to 2025 Medicare claims, Alexis Ogdie, MD (NPI: 1871657882) practices rheumatology in the Philadelphia, PA market, with the plurality of this provider's patient population coming from Philadelphia, PA. This provider's primary affiliated billing organization is UNIVERSITY OF PENN-MEDICAL GROUP (NPI: 1982717641; TIN: 232743545) and primary practice location at 19104-5127.

Ogdie's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 57 traditional Medicare patients, billed 151 HCPCS/CPT codes, and received $7,633 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 469 prescription claims across 57 beneficiaries totaling $1,051,617 in drug costs, led by Enbrel Sureclick (Etanercept). Open Payments data shows 104 records totaling $1,773,526. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has declined steadily, from $10,119 to $7,633. In contrast, Part D prescription costs have risen steadily, from $221,686 to $1,051,617. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$10K$20K2015 Medicare payment: $10,119 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $20,028 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $8,573 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $11,794 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $8,354 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $9,677 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $7,662 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $7,066 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $9,434 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $7,633 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
201559107$10,119
2016102251$20,028
201757109$8,573
201876142$11,794
201958110$8,354
202068120$9,677
20215790$7,662
20225493$7,066
202363113$9,434
202457151$7,633

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$736K$1.5M2015 Drug cost: $221,686 (USD; Tot_Drug_Cst)2016 Drug cost: $361,682 (USD; Tot_Drug_Cst)2017 Drug cost: $566,053 (USD; Tot_Drug_Cst)2018 Drug cost: $902,394 (USD; Tot_Drug_Cst)2019 Drug cost: $1,216,193 (USD; Tot_Drug_Cst)2020 Drug cost: $1,269,263 (USD; Tot_Drug_Cst)2021 Drug cost: $1,257,206 (USD; Tot_Drug_Cst)2022 Drug cost: $1,201,503 (USD; Tot_Drug_Cst)2023 Drug cost: $1,472,104 (USD; Tot_Drug_Cst)2024 Drug cost: $1,051,617 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
201540368$221,686
201659484$361,682
201755519$566,053
201848562$902,394
201960628$1,216,193
202056621$1,269,263
202175567$1,257,206
202265522$1,201,503
202382650$1,472,104
202457469$1,051,617

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more4365$68
G2211Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's3846$13

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Enbrel SureclickEtanercept471,316$336,610
TremfyaGuselkumab14424$176,949
Taltz AutoinjectorIxekizumab16448$148,644
OtezlaApremilast29870$136,565
ActemraTocilizumab12336$54,819

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.91$86,901Eli Lilly and Company
Research PaymentsReported research-related payment or transfer-of-value amount.13$1,686,625Hospital Of The Univ Of Penna
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Alexis Renae Ogdie, MD?

Tedicare shows public-source Medicare data for Alexis Renae Ogdie, MD (NPI 1871657882), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Alexis Renae Ogdie, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Alexis Renae Ogdie, MD?

Alexis Renae Ogdie, MD is linked to UNIVERSITY OF PENN-MEDICAL GROUP (billing NPI 1982717641) in the available physician profile data.

Does Alexis Renae Ogdie, MD have Open Payments data?

Alexis Renae Ogdie, MD has 104 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.